Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 25;26(11):3157.
doi: 10.3390/molecules26113157.

Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies

Tahereh Farkhondeh  1   2 , Ali Mohammad Pourbagher-Shahri  3 , Mohsen Azimi-Nezhad  4 , Fatemeh Forouzanfar  5 , Aranka Brockmueller  6 , Milad Ashrafizadeh  7   8 , Marjan Talebi  9 , Mehdi Shakibaei  6 , Saeed Samarghandian  4
Affiliations
Review

Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies

Tahereh Farkhondeh et al. Molecules. .

Abstract

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) is a specific transcription factor with potent effects on the regulation of antioxidant gene expression that modulates cell hemostasis under various conditions in tissues. However, the effects of Nrf2 on gastric cancer (GC) are not fully elucidated and understood. Evidence suggests that uncontrolled Nrf2 expression and activation has been observed more frequently in malignant tumors, including GC cells, which is then associated with increased antioxidant capacity, chemoresistance, and poor clinical prognosis. Moreover, Nrf2 inhibitors and the associated modulation of tumor cell redox balance have shown that Nrf2 also has beneficial effects on the therapy of various cancers, including GC. Based on previous findings on the important role of Nrf2 in GC therapy, it is of great interest to scientists in basic and clinical tumor research that Nrf2 can be active as both an oncogene and a tumor suppressor depending on different background situations.

Keywords: Nrf2 inhibitor; Nrf2 pathway; antioxidants; gastric cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The inhibitory effect of anti-HER2 drugs on Nrf2 inhibition and gastric cancer prevention.
Figure 2
Figure 2
Role of Nrf2 pathways in gastric cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wright N.A., Poulsom R., Stamp G., van Noorden S., Sarraf C., Elia G., Ahnen D., Jeffery R., Longcroft J., Pike C., et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 1993;104:12–20. doi: 10.1016/0016-5085(93)90830-6. - DOI - PubMed
    1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011;61:69–90. doi: 10.3322/caac.20107. - DOI - PubMed
    1. Abadi A.J., Zarrabi A., Hashemi F., Zabolian A., Najafi M., Entezari M., Hushmandi K., Aref A.R., Khan H., Makvandi P., et al. The role of SOX family transcription factors in gastric cancer. Int. J. Biol. Macromol. 2021;180:608–624. doi: 10.1016/j.ijbiomac.2021.02.202. - DOI - PubMed
    1. Stock M., Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1–19. doi: 10.1016/j.gene.2005.06.026. - DOI - PubMed
    1. Ashrafizadeh M., Zarrabi A., Hashemipour M., Vosough M., Najafi M., Shahinozzaman M., Hushmandi K., Khan H., Mirzaei H. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacol. Res. 2020;160:105199. - PubMed

MeSH terms